Kaufmann named Cardinal CEO, succeeding Barrett
Mike Kaufmann has been named chief executive officer of Cardinal Health Inc., effective January 1. The 54-year-old Kaufmann, Cardinal’s chief financial officer, will succeed George Barrett.
CDR
Ashworth promoted by WBA
Walgreens Boots Alliance Inc. (WBA) has promoted Richard Ashworth to president of operations at Walgreens, a newly created position.
NACDS: Pharmacy can be major player in opioid crisis
Pharmacy can be key to thwarting opioid abuse, National Association of Chain Drug Stores president and chief executive officer Steve Anderson told a government summit on the opioid crisis.
CVS to offer next-day prescription delivery
CVS Pharmacy will launch next-day prescription delivery nationwide in early 2018. As part of the CVS next-day prescription delivery rollout, same-day delivery will be available in selected cities, with the service beginning in New York next month.
McKesson buys RxCrossroads
McKesson Corp. has agreed to buy RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health. The deal, expected to close early next year, is valued at $735 million, or about $635 million net of the present value of incremental cash tax benefits.
Kmart offers memory screenings
Kmart Pharmacy has partnered with the Alzheimer’s Foundation of America (AFA) to offer free memory screenings. During November, which is Alzheimer’s Awareness Month and National Memory Screening Month, all Kmart Pharmacy U.S.
Peters appointed sales EVP at Diplomat
Robyn Peters has joined Diplomat Pharmacy in the role of executive vice president of sales and payor strategies. Peters, most recently vice president of market access and reimbursement at Biogen Inc.
Innovators drive expansion of health categories
New categories can develop when product innovation meets a consumer’s unmet need in a way that no existing category has provided. Retailers that adopt a new category or subcategory early can gain an edge over their competitors. Emerging retail categories disrupt and change the retail market.
AstraZeneca cleared to market Fasenra biologic for asthma
AstraZeneca plans to release Fasenra, its newly approved biologic drug for severe asthma, to U.S. pharmacies in the coming weeks.
Culturelle Baby probiotics line introduced
Culturelle is launching Culturelle Baby, a new line of probiotics formulated for children up to 24 months. The i-Health Inc.
Cardinal Health zeroes in on opioid abuse
Building on its efforts to fight the opioid abuse epidemic, Cardinal Health Inc. has launched an initiative targeting one of the nation’s hardest-hit areas.
Gretchen Carlson tabbed as NACDS Foundation Dinner speaker
News anchor and best-selling author Gretchen Carlson will speak at this month’s NACDS Foundation Dinner in New York City.
Walmart sees online sales boost in 3Q
Walmart reported better-than-expected comparable store sales gains in the third quarter. Walmart’s third quarter also include a strong performance by its online business, with net e-commerce sales increasing 50% in the quarter.
Diplomat Pharmacy buys LDI for $595 million
Diplomat Pharmacy Inc. plans to acquire St. Louis-based pharmacy benefit manager LDI Integrated Pharmacy Services for in a $595 million cash and stock deal. The move marks the second PBM acquisition this month by Diplomat, the nation’s largest independent specialty pharmacy. On Nov.
New high blood pressure standards impact Rx
For prescribers and pharmacists, the reduced levels for defining a person as having high blood pressure bring new guidelines for hypertension medication.